These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7922136)

  • 1. Synthesis of 1L-chiro-inositol 2,3,5-trisphosphorothioate, the first partial agonist at the platelet myo-inositol 1,4,5-trisphosphate receptor.
    Liu C; al-Hafidh J; Westwick J; Potter BV
    Bioorg Med Chem; 1994 Apr; 2(4):253-7. PubMed ID: 7922136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. myo-inositol 1,4,6-trisphosphorothioate and myo-inositol 1,3, 6-trisphosphorothioate: partial agonists with very low intrinsic activity at the platelet myo-inositol 1,4,5-trisphosphate receptor.
    Murphy CT; Riley AM; Mills SJ; Lindley CJ; Potter BV; Westwick J
    Mol Pharmacol; 2000 Mar; 57(3):595-601. PubMed ID: 10692501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of potent and selective inhibitors of myo-inositol 1,4,5-trisphosphate 5-phosphatase.
    Safrany ST; Mills SJ; Liu C; Lampe D; Noble NJ; Nahorski SR; Potter BV
    Biochemistry; 1994 Sep; 33(35):10763-9. PubMed ID: 8075077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of partial agonists with low intrinsic activity at the inositol-1,4,5-trisphosphate receptor.
    Safrany ST; Wilcox RA; Liu C; Dubreuil D; Potter BV; Nahorski SR
    Mol Pharmacol; 1993 Apr; 43(4):499-503. PubMed ID: 8386304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of selective non-Ca(2+)-mobilizing inhibitors of D-myo-inositol 1,4,5-trisphosphate 5-phosphatase.
    Lampe D; Liu C; Potter BV
    J Med Chem; 1994 Apr; 37(7):907-12. PubMed ID: 8151617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of D- and L-myo-inositol 2,4,5-trisphosphate and trisphosphorothioate: structural analogues of D-myo-inositol 1,4,5-trisphosphate.
    Mills SJ; Liu C; Potter BV
    Carbohydr Res; 2002 Nov; 337(20):1795-801. PubMed ID: 12431881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the minimal structural requirements for partial agonism at the type I myo-inositol 1,4,5-trisphosphate receptor.
    Wilcox RA; Fauq A; Kozikowski AP; Nahorski SR
    FEBS Lett; 1997 Feb; 402(2-3):241-5. PubMed ID: 9037203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enantiomers of myo-inositol-1,3,4-trisphosphate and myo-inositol-1,4,6 -trisphosphate: stereospecific recognition by cerebellar and platelet myo-inositol-1,4,5-trisphosphate receptors.
    Murphy CT; Bullock AJ; Lindley CJ; Mills SJ; Riley AM; Potter BV; Westwick J
    Mol Pharmacol; 1996 Nov; 50(5):1223-30. PubMed ID: 8913354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myo-inositol 1,3,4,5-tetrakisphosphate can independently mobilise intracellular calcium, via the inositol 1,4,5-trisphosphate receptor: studies with myo-inositol 1,4,5-trisphosphate-3-phosphorothioate and myo-inositol hexakisphosphate.
    Wilcox RA; Whitham EM; Liu C; Potter BV; Nahorski SR
    FEBS Lett; 1993 Dec; 336(2):267-71. PubMed ID: 8262243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, calcium mobilizing, and physicochemical properties of D-chiro-inositol 1,3,4,6-tetrakisphosphate, a novel and potent ligand at the D-myo-inositol 1,4,5-trisphosphate receptor.
    Liu C; Davis RJ; Nahorski SR; Ballereau S; Spiess B; Potter BV
    J Med Chem; 1999 Jun; 42(11):1991-8. PubMed ID: 10354407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inositol-1,3,4,5-tetrakisphosphate induces calcium mobilization via the inositol-1,4,5-trisphosphate receptor in SH-SY5Y neuroblastoma cells.
    Wilcox RA; Challiss RA; Liu C; Potter BV; Nahorski SR
    Mol Pharmacol; 1993 Oct; 44(4):810-7. PubMed ID: 8232232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-myo-inositol 1,4,5-trisphosphate analogues modified at the 3-position inhibit phosphatidylinositol 3-kinase.
    Ward SG; Mills SJ; Liu C; Westwick J; Potter BV
    J Biol Chem; 1995 May; 270(20):12075-84. PubMed ID: 7744856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic analysis of novel inhibitors of inositol polyphosphate metabolism.
    Hansbro PM; Foster PS; Liu C; Potter BV; Denborough MA
    Biochem Biophys Res Commun; 1994 Apr; 200(1):8-15. PubMed ID: 8166746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DL-myo-inositol 1,4,5-trisphosphorothioate mobilizes intracellular calcium in Swiss 3T3 cells and Xenopus oocytes.
    Taylor CW; Berridge MJ; Brown KD; Cooke AM; Potter BV
    Biochem Biophys Res Commun; 1988 Jan; 150(2):626-32. PubMed ID: 3342041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of synthetic D-6-deoxy-myo-inositol 1,4,5-trisphosphate with the Ca2(+)-releasing D-myo-inositol 1,4,5-trisphosphate receptor, and the metabolic enzymes 5-phosphatase and 3-kinase.
    Safrany ST; Wojcikiewicz RJ; Strupish J; Nahorski SR; Dubreuil D; Cleophax J; Gero SD; Potter BV
    FEBS Lett; 1991 Jan; 278(2):252-6. PubMed ID: 1846823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural analogues of D-myo-inositol-1,4,5-trisphosphate and adenophostin A: recognition by cerebellar and platelet inositol-1,4,5-trisphosphate receptors.
    Murphy CT; Riley AM; Lindley CJ; Jenkins DJ; Westwick J; Potter BV
    Mol Pharmacol; 1997 Oct; 52(4):741-8. PubMed ID: 9380038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of (+/-)-2-O-[4'-(N-9''-purinyl)butyl] myo-inositol 1,4,5-tris(phosphate), a potent full agonist at the D-myo-inositol 1,4,5-tris(phosphate) receptor.
    Moris MA; Caron AZ; Guillemette G; Rognan D; Schmitt M; Schlewer G
    J Med Chem; 2005 Feb; 48(4):1251-5. PubMed ID: 15715492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereospecific mobilization of intracellular Ca2+ by inositol 1,4,5-triphosphate. Comparison with inositol 1,4,5-trisphosphorothioate and inositol 1,3,4-trisphosphate.
    Strupish J; Cooke AM; Potter BV; Gigg R; Nahorski SR
    Biochem J; 1988 Aug; 253(3):901-5. PubMed ID: 3263119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and Ca(2+)-release activity of D- and L-myo-inositol 2,4,5-trisphosphate and D- and L-chiro-inositol 1,3,4-trisphosphate.
    Tegge W; Denis GV; Ballou CE
    Carbohydr Res; 1991 Sep; 217():107-16. PubMed ID: 1797394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of myo-inositol 1,4,5-trisphosphorothioate on Cl- current pattern and intracellular Ca2+ in the Xenopus laevis oocyte.
    Ferguson JE; Potter B; Nuccitelli R
    Biochem Biophys Res Commun; 1990 Oct; 172(1):229-36. PubMed ID: 1699536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.